Elena de Lisa

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Miguel Á. Sanz, Pau Montesinos, Chelo Rayón et al. · Blood · 2010 · 336 citations · Full text

Medicine, Oncology, Pharmacology +16

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-<i>Trans</i>-Retinoic Acid and Anthracycline-Based Chemotherapy

Pau Montesinos, José D. González, José González et al. · Journal of Clinical Oncology · 2010 · 72 citations · Full text

Medicine, Hematology, Oncology +15

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

Miguel Á. Sanz, Pau Montesinos, Haesook T. Kim et al. · Annals of Hematology · 2015 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia

Miguel Á. Sanz, Pau Montesinos, María F. Casale et al. · Annals of Hematology · 2015 · 22 citations

Public Health, Maternal Health, Obstetrics +16